[新型喹诺酮类药物]
[The new quinolones].
作者信息
Lontie M
出版信息
J Pharm Belg. 1989 Jul-Aug;44(4):292-301.
PMID:2691640
Abstract
The new quinolones are reviewed. These drugs are fluorinated derivatives of nalidixic acid, like ciprofloxacin, norfloxacin, ofloxacin, pefloxacin, and others. The following aspects are discussed: microbiology, modes of action and of resistance, the pharmacologic properties, the adverse reactions, the interactions with other drugs, and the principal clinical applications.
摘要
对新型喹诺酮类药物进行了综述。这些药物是萘啶酸的氟化衍生物，如环丙沙星、诺氟沙星、氧氟沙星、培氟沙星等。讨论了以下几个方面：微生物学、作用方式与耐药性、药理特性、不良反应、与其他药物的相互作用以及主要临床应用。
相似文献
1
[The new quinolones].
J Pharm Belg. 1989 Jul-Aug;44(4):292-301.
2
Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
Drugs Exp Clin Res. 1989;15(1):11-5.
3
[Therapeutic contribution of the new quinolones].
Rev Prat. 1987 Apr 11;37(21):1209-14.
4
In vitro antimicrobial interactions of arthemeter with some 4-quinolones.
Boll Chim Farm. 2002 Sep-Oct;141(5):385-8.
5
The quinolones.
Infect Dis Clin North Am. 1989 Sep;3(3):625-39.
6
In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Chemioterapia. 1988 Oct;7(5):287-91.
7
[In vitro evaluation of lomefloxacin].
Arzneimittelforschung. 1989 Aug;39(8):832-5.
8
Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
Chemioterapia. 1987 Apr;6(2):75-8.
9
Overview of the fluoroquinolone antibiotics.
Pharmacotherapy. 1993 Mar-Apr;13(2 Pt 2):4S-17S.
10
The evolution of fluorinated quinolones: pharmacology, microbiological activity, clinical uses, and toxicities.
Annu Rev Microbiol. 1989;43:601-27. doi: 10.1146/annurev.mi.43.100189.003125.
Zotero 插件